Asinex specializes in the development of advanced screening libraries utilizing DNA-encoded chemistry, which allows for the efficient synthesis and screening of vast compound libraries. Their focus on macrocyclic intermediates and conjugates enables the creation of innovative DNA-macrocycle conjugates and DNA-encoded libraries (DEL). The company emphasizes the importance of integrating their expertise in chemistry, biology, and computer science to enhance the design and functionality of these libraries. This approach facilitates the discovery of novel protein degraders, E3 ligase ligands, and covalent inhibitors, which are crucial for advancing drug discovery and development.

In addition to their work with macrocycles, Asinex offers a range of building blocks and fragments that are essential for constructing diverse chemical libraries. Their commitment to speed chemistry allows for rapid development and optimization of these building blocks, which are tailored for use in DNA-encoded libraries. By leveraging their knowledge in cellular permeability and computational small molecule design, Asinex aims to create high-quality screening libraries that can significantly accelerate the drug discovery process and lead to the identification of promising therapeutic candidates.

Russia

Asinex.com is a biotechnology company that specializes in creating new screening libraries by combining expertise in chemistry, biology, and computer science.

Asinex

Company Details